Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells Harboring HIV In Situ.

Vasquez JJ, Hussien R, Aguilar-Rodriguez B, Junger H, Dobi D, Henrich TJ, Thanh C, Gibson E, Hogan LE, McCune J, Hunt PW, Stoddart CA, Laszik ZG.

J Histochem Cytochem. 2018 Feb 1:22155418756848. doi: 10.1369/0022155418756848. [Epub ahead of print]

PMID:
29462571
2.

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.

Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG.

PLoS Med. 2017 Nov 7;14(11):e1002417. doi: 10.1371/journal.pmed.1002417. eCollection 2017 Nov.

3.

Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.

Henrich TJ, Hobbs KS, Hanhauser E, Scully E, Hogan LE, Robles YP, Leadabrand KS, Marty FM, Palmer CD, Jost S, Körner C, Li JZ, Gandhi RT, Hamdan A, Abramson J, LaCasce AS, Kuritzkes DR.

J Infect Dis. 2017 Jul 15;216(2):254-262. doi: 10.1093/infdis/jix265.

PMID:
28838149
4.

Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.

Hill AL, Rosenbloom DIS, Goldstein E, Hanhauser E, Kuritzkes DR, Siliciano RF, Henrich TJ.

PLoS Pathog. 2017 Jul 6;13(7):e1006488. doi: 10.1371/journal.ppat.1006488. eCollection 2017 Jul.

5.

High-throughput Characterization of HIV-1 Reservoir Reactivation Using a Single-Cell-in-Droplet PCR Assay.

Yucha RW, Hobbs KS, Hanhauser E, Hogan LE, Nieves W, Ozen MO, Inci F, York V, Gibson EA, Thanh C, Shafiee H, El Assal R, Kiselinova M, Robles YP, Bae H, Leadabrand KS, Wang S, Deeks SG, Kuritzkes DR, Demirci U, Henrich TJ.

EBioMedicine. 2017 Jun;20:217-229. doi: 10.1016/j.ebiom.2017.05.006. Epub 2017 May 4.

6.

Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies.

Henrich TJ, Deeks SG, Pillai SK.

J Infect Dis. 2017 Mar 15;215(suppl_3):S134-S141. doi: 10.1093/infdis/jiw648. Review.

PMID:
28520968
7.

A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.

Charlins P, Schmitt K, Remling-Mulder L, Hogan LE, Hanhauser E, Hobbs KS, Hecht F, Deeks SG, Henrich TJ, Akkina R.

Virology. 2017 Jul;507:135-139. doi: 10.1016/j.virol.2017.04.011. Epub 2017 Apr 19.

PMID:
28432928
8.

International AIDS Society global scientific strategy: towards an HIV cure 2016.

Deeks SG, Lewin SR, Ross AL, Ananworanich J, Benkirane M, Cannon P, Chomont N, Douek D, Lifson JD, Lo YR, Kuritzkes D, Margolis D, Mellors J, Persaud D, Tucker JD, Barre-Sinoussi F; International AIDS Society Towards a Cure Working Group, Alter G, Auerbach J, Autran B, Barouch DH, Behrens G, Cavazzana M, Chen Z, Cohen ÉA, Corbelli GM, Eholié S, Eyal N, Fidler S, Garcia L, Grossman C, Henderson G, Henrich TJ, Jefferys R, Kiem HP, McCune J, Moodley K, Newman PA, Nijhuis M, Nsubuga MS, Ott M, Palmer S, Richman D, Saez-Cirion A, Sharp M, Siliciano J, Silvestri G, Singh J, Spire B, Taylor J, Tolstrup M, Valente S, van Lunzen J, Walensky R, Wilson I, Zack J.

Nat Med. 2016 Aug;22(8):839-50. doi: 10.1038/nm.4108. Epub 2016 Jul 11.

9.

INTERACTIVE MEDICAL CASE. A Woman with Dyspnea and Altered Mental Status.

Patel KP, Vaidya A, Gibson CJ, Henrich TJ, Lyons JL.

N Engl J Med. 2016 Jun 9;374(23):e29. doi: 10.1056/NEJMimc1510029. No abstract available.

10.

Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring.

Lifson MA, Ozen MO, Inci F, Wang S, Inan H, Baday M, Henrich TJ, Demirci U.

Adv Drug Deliv Rev. 2016 Aug 1;103:90-104. doi: 10.1016/j.addr.2016.05.018. Epub 2016 Jun 2. Review.

11.

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.

Hill AL, Rosenbloom DI, Goldstein E, Hanhauser E, Kuritzkes DR, Siliciano RF, Henrich TJ.

PLoS Pathog. 2016 Apr 27;12(4):e1005535. doi: 10.1371/journal.ppat.1005535. eCollection 2016 Apr. Erratum in: PLoS Pathog. 2016 Jul;12(7):e1005778. PLoS Pathog. 2017 Jul 6;13(7):e1006488.

12.

Ethics of ART interruption after stem-cell transplantation.

Sugarman J, Lewin SR, Henrich TJ, Rasmussen TA.

Lancet HIV. 2016 Jan;3(1):e8-10. doi: 10.1016/S2352-3018(15)00248-9. No abstract available.

PMID:
26762996
13.

CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy.

Henrich TJ, Hanhauser E, Harrison LJ, Palmer CD, Romero-Tejeda M, Jost S, Bosch RJ, Kuritzkes DR.

J Infect Dis. 2016 Mar 1;213(5):766-70. doi: 10.1093/infdis/jiv504. Epub 2015 Oct 28.

14.

Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1.

Rosenbloom DI, Elliott O, Hill AL, Henrich TJ, Siliciano JM, Siliciano RF.

Open Forum Infect Dis. 2015 Aug 26;2(4):ofv123. doi: 10.1093/ofid/ofv123. eCollection 2015 Dec. Review.

15.

HIV eradication: is cord blood the answer?

Henrich TJ.

Lancet HIV. 2015 Jun;2(6):e219-20. doi: 10.1016/S2352-3018(15)00088-0. Epub 2015 May 19. No abstract available.

PMID:
26423188
16.

Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics.

Inci F, Filippini C, Baday M, Ozen MO, Calamak S, Durmus NG, Wang S, Hanhauser E, Hobbs KS, Juillard F, Kuang PP, Vetter ML, Carocci M, Yamamoto HS, Takagi Y, Yildiz UH, Akin D, Wesemann DR, Singhal A, Yang PL, Nibert ML, Fichorova RN, Lau DT, Henrich TJ, Kaye KM, Schachter SC, Kuritzkes DR, Steinmetz LM, Gambhir SS, Davis RW, Demirci U.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4354-63. doi: 10.1073/pnas.1510824112. Epub 2015 Jul 20.

17.

Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva.

Shafiee H, Kanakasabapathy MK, Juillard F, Keser M, Sadasivam M, Yuksekkaya M, Hanhauser E, Henrich TJ, Kuritzkes DR, Kaye KM, Demirci U.

Sci Rep. 2015 Jun 5;5:9919. doi: 10.1038/srep09919.

18.

Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study.

Henrich TJ, McLaren PJ, Rao SS, Lin NH, Hanhauser E, Giguel F, Gulick RM, Ribaudo H, de Bakker PI, Kuritzkes DR.

Open Forum Infect Dis. 2014 May 22;1(1):ofu018. doi: 10.1093/ofid/ofu018. eCollection 2014 Mar.

19.

Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32.

Henrich TJ, Hanhauser E, Hu Z, Stellbrink HJ, Noah C, Martin JN, Deeks SG, Kuritzkes DR, Pereyra F.

AIDS. 2015 May 15;29(8):867-76. doi: 10.1097/QAD.0000000000000629.

20.

Emerging technologies for point-of-care management of HIV infection.

Shafiee H, Wang S, Inci F, Toy M, Henrich TJ, Kuritzkes DR, Demirci U.

Annu Rev Med. 2015;66:387-405. doi: 10.1146/annurev-med-092112-143017. Epub 2014 Nov 12. Review.

PMID:
25423597
21.

Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.

Henrich TJ, Hanhauser E, Marty FM, Sirignano MN, Keating S, Lee TH, Robles YP, Davis BT, Li JZ, Heisey A, Hill AL, Busch MP, Armand P, Soiffer RJ, Altfeld M, Kuritzkes DR.

Ann Intern Med. 2014 Sep 2;161(5):319-27. doi: 10.7326/M14-1027.

22.

Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion.

Al-Hajjar SH, Frayha HH, Al-Hazmi M, Batawi R, McIntosh K, Sax PE, Al-Thawadi S, Al-Jumaah S, Busch MP, Hanhauser E, Kuritzkes DR, Li JZ, Henrich TJ.

AIDS. 2014 Jun 19;28(10):1539-41. doi: 10.1097/QAD.0000000000000268. No abstract available.

23.

Nanostructured optical photonic crystal biosensor for HIV viral load measurement.

Shafiee H, Lidstone EA, Jahangir M, Inci F, Hanhauser E, Henrich TJ, Kuritzkes DR, Cunningham BT, Demirci U.

Sci Rep. 2014 Feb 28;4:4116. doi: 10.1038/srep04116.

24.

HIV-1 persistence in CD4+ T cells with stem cell-like properties.

Buzon MJ, Sun H, Li C, Shaw A, Seiss K, Ouyang Z, Martin-Gayo E, Leng J, Henrich TJ, Li JZ, Pereyra F, Zurakowski R, Walker BD, Rosenberg ES, Yu XG, Lichterfeld M.

Nat Med. 2014 Feb;20(2):139-42. doi: 10.1038/nm.3445. Epub 2014 Jan 12.

25.

Early treatment and HIV-1 reservoirs: a stitch in time?

Henrich TJ, Gandhi RT.

J Infect Dis. 2013 Oct 15;208(8):1189-93. doi: 10.1093/infdis/jit307. Epub 2013 Jul 12. No abstract available.

26.

Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation.

Henrich TJ, Hu Z, Li JZ, Sciaranghella G, Busch MP, Keating SM, Gallien S, Lin NH, Giguel FF, Lavoie L, Ho VT, Armand P, Soiffer RJ, Sagar M, Lacasce AS, Kuritzkes DR.

J Infect Dis. 2013 Jun 1;207(11):1694-702. doi: 10.1093/infdis/jit086. Epub 2013 Mar 4.

27.

HIV-1 entry inhibitors: recent development and clinical use.

Henrich TJ, Kuritzkes DR.

Curr Opin Virol. 2013 Feb;3(1):51-7. doi: 10.1016/j.coviro.2012.12.002. Epub 2013 Jan 3. Review.

28.

Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mL.

Henrich TJ, Wood BR, Kuritzkes DR.

PLoS One. 2012;7(11):e50065. doi: 10.1371/journal.pone.0050065. Epub 2012 Nov 15.

29.

Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR.

Henrich TJ, Gallien S, Li JZ, Pereyra F, Kuritzkes DR.

J Virol Methods. 2012 Dec;186(1-2):68-72. doi: 10.1016/j.jviromet.2012.08.019. Epub 2012 Sep 4.

30.

HIV-2 encephalitis: case report and literature review.

Wood BR, Klein JP, Lyons JL, Milner DA, Phillips RE, Schutten M, Folkerth RD, Ciarlini P, Henrich TJ, Johnson JA.

AIDS Patient Care STDS. 2012 Jul;26(7):383-7. doi: 10.1089/apc.2012.0048. Epub 2012 Jun 13. Review.

PMID:
22694171
31.

Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists.

Henrich TJ, Lewine NR, Lee SH, Rao SS, Berro R, Gulick RM, Moore JP, Tsibris AM, Kuritzkes DR.

Antimicrob Agents Chemother. 2012 Apr;56(4):1931-5. doi: 10.1128/AAC.06061-11. Epub 2012 Jan 17.

32.

SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses.

Tsibris AM, Pal U, Schure AL, Veazey RS, Kunstman KJ, Henrich TJ, Klasse PJ, Wolinsky SM, Kuritzkes DR, Moore JP.

PLoS One. 2011;6(12):e28047. doi: 10.1371/journal.pone.0028047. Epub 2011 Dec 2.

33.

HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.

Putcharoen O, Lee SH, Henrich TJ, Hu Z, Vanichanan J, Coakley E, Greaves W, Gulick RM, Kuritzkes DR, Tsibris AM.

J Virol. 2012 Jan;86(2):1119-28. doi: 10.1128/JVI.06421-11. Epub 2011 Nov 16.

34.

Impact of age, gender, and pregnancy on syphilis screening using the Captia Syphilis-G assay.

Henrich TJ, Yawetz S.

Sex Transm Dis. 2011 Dec;38(12):1126-30. doi: 10.1097/OLQ.0b013e31822e60e1.

PMID:
22082723
35.

Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions.

Henrich TJ, Li JZ, Felsenstein D, Kotton CN, Plenge RM, Pereyra F, Marty FM, Lin NH, Grazioso P, Crochiere DM, Eggers D, Kuritzkes DR, Tsibris AM.

J Infect Dis. 2010 Nov 15;202(10):1478-81. doi: 10.1086/657168. Epub 2010 Oct 11.

36.

Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate.

Henrich TJ, Tsibris AM, Lewine NR, Konstantinidis I, Leopold KE, Sagar M, Kuritzkes DR.

J Acquir Immune Defic Syndr. 2010 Dec;55(4):420-7. doi: 10.1097/QAI.0b013e3181f25574.

37.

Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy.

Henrich TJ, Ribaudo HJ, Kuritzkes DR.

Clin Infect Dis. 2010 Jul 1;51(1):93-8. doi: 10.1086/653430.

38.

Infectious granulomatous dermatitis associated with Rothia mucilaginosa bacteremia: A case report.

Morgan EA, Henrich TJ, Jarell AD, Shieh WJ, Zaki SR, Marty FM, Thorner AR, Milner DA, Velazquez EF.

Am J Dermatopathol. 2010 Apr;32(2):175-9. doi: 10.1097/DAD.0b013e3181b1c5ad.

PMID:
19940746
39.

Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature.

Henrich TJ, Marty FM, Milner DA Jr, Thorner AR.

Transpl Infect Dis. 2009 Oct;11(5):458-62. doi: 10.1111/j.1399-3062.2009.00418.x. Review.

PMID:
19804480
40.

Clinical risk factors for severe Clostridium difficile-associated disease.

Henrich TJ, Krakower D, Bitton A, Yokoe DS.

Emerg Infect Dis. 2009 Mar;15(3):415-22. doi: 10.3201/eid1503.080312.

41.

Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.

Tsibris AM, Paredes R, Chadburn A, Su Z, Henrich TJ, Krambrink A, Hughes MD, Aberg JA, Currier JS, Tashima K, Godfrey C, Greaves W, Flexner C, Skolnik PR, Wilkin TJ, Gulick RM, Kuritzkes DR.

Clin Infect Dis. 2009 Mar 1;48(5):642-9. doi: 10.1086/597007.

42.
43.

Geographic dynamics of viral encephalitis in Thailand.

Henrich TJ, Hutchaleelaha S, Jiwariyavej V, Barbazan P, Nitatpattana N, Yoksan S, Gonzalez JP.

Microbes Infect. 2003 Jun;5(7):603-11.

PMID:
12787736

Supplemental Content

Loading ...
Support Center